FDA Approved: BACLOFEN — Supplemental Application (Endo USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Baclofen from Endo USA, Inc. (ANDA077068).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Palsy
• Multiple Sclerosis
• Spinal Cord Injury

Drugs mentioned

• BACLOFEN (Baclofen)

Snippet

SUPPL AP for BACLOFEN (BACLOFEN)